Celltrion
068270.KS
#724
Rank
A$43.69 B
Marketcap
$213.20
Share price
0.05%
Change (1 day)
0.13%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Net assets

Net assets on the balance sheet as of September 2024 : A$20.80 Billion

According to Celltrion 's latest financial reports the company has A$20.80 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Celltrion - Net assets on balance sheet (from 2007 to 2024)

Net assets by year

Year Net assets Change
2022-12-31$A$4.98 B6.09%
2021-12-31$A$4.69 B14.43%
2020-12-31$A$4.10 B15.63%
2019-12-31$A$3.54 B7.53%
2018-12-31$A$3.30 B13.95%
2017-12-31$A$2.89 B22.11%
2016-12-31$A$2.37 B19.27%
2015-12-31$A$1.98 B32.25%
2014-12-31$A$1.50 B30.06%
2013-12-31$A$1.15 B18.75%
2012-12-31$A$0.97 B28.65%
2011-12-31$A$0.75 B11.08%
2010-12-31$A$0.68 B146.57%
2009-12-31$A$0.27 B10.2%
2008-12-31$A$0.25 B663.62%
2007-12-31$A$32.83 M